Evaluation of Resynchronization Therapy for Heart Failure (EARTH)

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Heart Failure
Interventions
DEVICE

Device programming

6-month period

Trial Locations (11)

T6G 2B7

University of Alberta Hospital, Edmonton

V6Z 1Y6

St-Paul's Hospital, Vancouver

B3H 3A7

QEII Health Sciences Centre, Halifax

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

M4N 3M5

Sunnybrook & Women's Hospital, Toronto

M5B 1W8

St-Michael's Hospital, Toronto

J1H 5N4

CHUS-Fleurimont, Fleurimont

H1T1C8

Montreal Heart Institute, Montreal

H2W 1T8

CHUM-Hôpital Hotel-Dieu, Montreal

H4J 1C5

Sacre-Coeur Hospital, Montreal

G1V 4G5

Institut Univ de Cardiologie et de Pneumologie de Québec, Québec

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Montreal Heart Institute

OTHER